Detalhe da pesquisa
1.
A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
J Transl Med
; 22(1): 90, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254099
2.
Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy.
Lipids Health Dis
; 22(1): 45, 2023 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004014
3.
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes.
Oncoimmunology
; 13(1): 2303195, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235318
4.
Association of genes in hereditary metabolic diseases with diagnosis, prognosis, and treatment outcomes in gastric cancer.
Front Immunol
; 14: 1289700, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022516
5.
m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy.
Front Immunol
; 14: 1326031, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187373
6.
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers.
Cancers (Basel)
; 14(23)2022 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497375
7.
A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint Inhibitors.
Front Cell Dev Biol
; 10: 862294, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35557959